Recent Reports


2010-03-11: Health Care IT Report
6 leading Analysts; and top management from 1 Sector Firm examine this vital industry in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

2010-01-25: Medical Research, Diagnostic Substances, Life Science Tools Report
7 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 38 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Consumer Health Services Report
7 leading Analysts; and top management from 2 Sector Firm examine this vital industry in this 53 page report from The Wall Street Transcript.
More Information
Order this Report

2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

2009-10-19: Biotechnology Report
3 leading Analysts; 2 Money Managers; and top management from 12 Sector Firms examine this vital industry in this 70 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Real Estate: Healthcare REITs, Long-Term Care Facilities & Hospitals Report
3 analysts and 6 sector firms examine the medical real estate segment in this 45 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Devices Report
4 analysts and 7 sector firms examine the medical devices segment in this 41 page report from The Wall Street Transcript.
More Information
Order this Report

09.14.09: Medical Research Services Report
2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
ROY WHITFIELD - INCYTE GENOMICS INC (INCY)


Full article published: 10/05/2000


For Subscribers

Get this article online now!

Order just this article
TWST: Would you provide our readers with a brief overview of Incyte Genomics?
Mr. Whitfield: Quite simply, Incyte has produced and distributes the world's largest and most comprehensive database of genomic information. We work with 19 of the top 20 pharmaceutical companies, an increasing number of the biotechnology companies, and now through the Internet, academic researchers worldwide.

TWST: What do you see as the most significant trends or developments in the field of genomics?
Mr. Whitfield: The need to integrate all the various types of genomic information. Genomics has moved rapidly in the last couple of years from beyond sequence information and the simple type of information you get from the human genome project, to more detailed and valuable types of genomic information, like gene expression data, proteomic information, information on genetic variation. All this information is much closer to the ultimate biology and solution to diseases, but is much more complex and needs greater horsepower from an information processing point of view. We're in the lead in all of that, so the whole strategy is to be out in front in all of those developments.

 

Tickers included in this excerpt: INCY

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.